• Login
    View Item 
    •   Oxy Scholar Home
    • Biology
    • Biology URC Student Scholarship
    • View Item
    •   Oxy Scholar Home
    • Biology
    • Biology URC Student Scholarship
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Genetic Engineering and Characterization of ZHTc6 and AF5 Cell Lines

    Thumbnail
    Author
    Leith, Margaret
    Issue
    urc_student; urc_student
    Date
    2009-01-01 0:00
    Metadata
    Show full item record
    URI
    https://scholar.oxy.edu/handle/20.500.12711/452
    Abstract
    Every year over 180,000 Americans are diagnosed with epilepsy, a chronic neurodegenerative disorder that is characterized by severe and unprovoked spontaneous seizures. Temporal lobe epilepsy (TLE) is particularly difficult to treat with conventional anti-epileptic drug therapy, and cell replacement therapy provides a promising alternative to temporal lobectomy (the removal of brain tissue containing the seizure focus). In preclinical trials, cells genetically engineered to secrete anticonvulsant molecules have been transplanted into the brain with some evidence of seizure suppression. One of these molecules, γ-aminobutyric acid (GABA), is an inhibitory amino acid that suppresses overly active neurons in seizure-susceptible regions of the brain. We transfect glutamic acid decarboxylase (GAD), an enzyme that converts glutamate to GABA, into cells that can be transplanted into animal models of epilepsy. The lab is currently working with a murine embryonic stem cell (ESC) line (ZHTc6), and has been developing protocols to promote their differentiation along a neural pathway; a neural cell line (AF5), derived from rat striatum, is used as a control. We show that both cell lines can be engineered to express reporter molecules (beta-galactosidase or green fluorescent protein) and GAD. High performance liquid chromatography illustrates that both cell lines produce GABA, and histochemistry and fluorescent microscopy show the detection of both cell lines in vitro. Our results suggest the possibility of developing therapeutic cells lines for TLE that can be differentiated prior to transplantation and identified in the host brain after transplantation?results relevant to all neurodegenerative disorders that are candidates for cell-based therapies.
    Collections
    • Biology URC Student Scholarship

    Browse

    All of Oxy ScholarCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsJournal TitleJournal IssueThis CollectionBy Issue DateAuthorsTitlesSubjectsJournal TitleJournal Issue

    My Account

    LoginRegister

    DSpace software copyright © 2002-2021  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV